We have designed a new family of readily available highly‐modular phosphite‐phosphoramidite ligands for asymmetric allylic alkylation reactions. The introduction of a phosphoramidite moiety in the ligand design is highly advantageous in the product outcome. Thus, this ligand series affords high reaction rates and enantioselectivities and, at the same time, shows a broad scope for disubstituted hindered and unhindered substrate types.
No takes yet. Share an insight, caveat, or question.
Pàmies et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: